Search Results - "Kamya, M"

Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa by Sabapathy, K, Balzer, L, Larmarange, J, Block, L, Floyd, S, Iwuji, C, Wirth, K, Ayles, H, Fidler, S, Kamya, M, Petersen, M, Havlir, D, Dabis, F, Moore, J, Hayes, R

“…Four large community-randomized trials examining universal testing and treatment (UTT) to reduce HIV transmission were conducted between 2012-2018 in Botswana,…”
Get full text

Antiretroviral Therapy With Efavirenz Accentuates Pregnancy‐Associated Reduction of Dihydroartemisinin‐Piperaquine Exposure During Malaria Chemoprevention by Kajubi, R, Huang, L, Jagannathan, P, Chamankhah, N, Were, M, Ruel, T, Koss, CA, Kakuru, A, Mwebaza, N, Kamya, M, Havlir, D, Dorsey, G, Rosenthal, PJ, Aweeka, FT

“…Dihydroartemisinin (DHA)‐piperaquine is promising for malaria chemoprevention in pregnancy. We assessed the impacts of pregnancy and efavirenz‐based…”
Get full text

Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda by Sung, J., Musinguzi, A., Kadota, J. L., Baik, Y., Nabunje, J., Welishe, F., Bishop, O., Berger, C. A., Katahoire, A., Nakitende, A., Nakimuli, J., Akello, L., Kasidi, J. R., Kunihira Tinka, L., Kamya, M. R., Sohn, H., Kiwanuka, N., Katamba, A., Cattamanchi, A., Dowdy, D. W., Semitala, F. C.

“…BACKGROUND: Twelve weeks of weekly isoniazid and rifapentine (3HP) prevents TB disease among people with HIV (PWH), but the costs to people of taking TB…”
Get full text

Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients by Sekaggya-Wiltshire, C, von Braun, A, Scherrer, A U, Manabe, Y C, Buzibye, A, Muller, D, Ledergerber, B, Gutteck, U, Corti, N, Kambugu, A, Byakika-Kibwika, P, Lamorde, M, Castelnuovo, B, Fehr, J, Kamya, M R

“…Toxicities due to anti-TB treatment frequently occur among TB/HIV-coinfected patients. To determine the association between anti-TB drug concentrations and the…”
Get full text

Cost-effectiveness analysis of PBO-LLINs compared to Non PBO LLINs in the reduction of malaria among children in Jinja district by Kaakyo, M., Muhumuza, C., Gonahasa, S., Hemingway, J., Donnelly, M., Kamya, M., Staedke, S., Kagaayi, J.

Get full text

Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy by Kadota, J. L., Katamba, A., Musinguzi, A., Welishe, F., Nabunje, J., Ssemata, J. L., Berger, C. A., Kamya, M. R., Namusobya, J., Semitala, F. C., Cattamanchi, A., Dowdy, D. W.

Get full text

Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda by Wekesa, C., Kirenga, B. J., Joloba, M. L., Bwanga, F., Katamba, A., Kamya, M. R.

“…SETTING: An out-patient clinic in a country with high rates of tuberculosis-human immunodeficiency virus (TB-HIV) co-infection.DESIGN: Cross-sectional…”
Get full text

Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda by Namutebi, A.M.N, Kamya, M.R.K, Byakika-Kibwika, P

“…Background: Cohorts describing cause specific mortality in HIV-infected patients initiating antiretroviral therapy (ART) operate on an outpatient basis…”
Get full text

Response to Antiretroviral Therapy in HIV-Infected Patients Attending a Public, Urban Clinic in Kampala, Uganda by Spacek, Lisa A., Shihab, Hasan M., Kamya, Moses R., Mwesigire, Doris, Ronald, Allan, Mayanja, Harriet, Moore, Richard D., Bates, Michael, Quinn, Thomas C.

“…Background. Access to antiretroviral therapy and human immunodeficiency virus (HIV) care is increasing in resource-limited settings. We evaluated clinical,…”
Get full text

Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan Africa by Castelnuovo, B, Sempa, J, Nyakato, P, Musaazi, J, Kambugu, A, Kamya, M, Kiragga, A

Get full text

Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda by NAKANJAKO, D, MAYANJA-KIZZA, H, OUMA, J, WANYENZE, R, MWESIGIRE, D, NAMALE, A, SSEMPIIRA, J, SENKUSU, J, COLEBUNDERS, R, KAMYA, M. R

“…Mulago Hospital, Uganda. To evaluate the burden of TB-HIV (tuberculosis-human immunodeficiency virus) co-infections and their predictors in an urban…”
Get full text

Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda by Ocama, P, Castelnuovo, B, Kamya, M R, Kirk, G D, Reynolds, S J, Kiragga, A, Colebunders, R, Thomas, D L

“…Liver enzyme elevations among patients on antiretroviral therapy (ART) were determined by prospectively evaluating aspartate aminotransferase (AST) data in a…”
Get more information

Evaluating the epidemiology of P. falciparum parasitemia in three areas of Uganda with different transmission intensities by Obasi, H., Rek, J., Nayebare, P., Katureeba, A., Kakande, E., Arinaitwe, E., Staedke, S., Kamya, M., Katrak, S., Jagannathan, P., Dorsey, G., Greenhouse, B.

Get full text

Structured career development for global health research in resource-limited settings: A pilot of career development series for faculty at Makerere university college of health sciences by Nakanjako, D., Kaye, D., Kambugu, A., Okello, E., Kamya, M., Tumwine, J., Mayanja-Kizza, H.

Get full text

Mentoring for sustainable in-country academic leadership in resource-limited settings by Nakanjako, D., Kaye, D., Kambugu, A., Okello, E., Kamya, M., Tumwine, J., Mayanja-Kizza, H.

Get full text

Increasing antimalarial drug resistance in Uganda and revision of the national drug policy by Kamya, M. R., Bakyaita, N. N., Talisuna, A. O., Were, W. M., Staedke, S. G.

“…Summary Chloroquine (CQ) resistance was first documented in Uganda in 1988. Subsequent surveillance of antimalarial drug resistance, conducted by the Ugandan…”
Get full text

Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda by Spacek, L A, Lutwama, F, Shihab, H M, Summerton, J, Kamya, M R, Ronald, A, Laeyendecker, O, Quinn, T C, Mayanja-Kizza, H

“…We evaluated the accuracy of heat-denatured, amplification-boosted ultrasensitive p24 assay (Up24) compared with reverse transcriptase polymerase chain…”
Get more information

Health care related factors associated with severe malaria in children in Kampala, Uganda by Byakika-Kibwika, P, Ndeezi, G, Kamya, M R

“…Severe malaria is responsible for the high load of malaria mortality. It is not clearly understood why some malaria episodes progress to severe malaria. To…”
Get full text

Artemisinin-Based Combination Therapies Are Efficacious and Safe for Treatment of Uncomplicated Malaria in HIV-Infected Ugandan Children by Kakuru, Abel, Achan, Jane, Muhindo, Mary K., Ikilezi, Gloria, Arinaitwe, Emmanuel, Mwangwa, Florence, Ruel, Theodore, Clark, Tamara D., Charlebois, Edwin, Rosenthal, Philip J., Havlir, Diane, Kamya, Moses R., Tappero, Jordan W., Dorsey, Grant

“…Background. Artemisinin-based combination therapies (ACTs) are highly efficacious and safe, but data from human immunodeficiency virus (HIV)–infected children…”
Get full text

Effect of HIV-1 Infection on Antimalarial Treatment Outcomes in Uganda: A Population-Based Study by Kamya, Moses R., Gasasira, Anne F., Yeka, Adoke, Bakyaita, Nathan, Nsobya, Samuel L., Francis, Damon, Rosenthal, Philip J., Dorsey, Grant, Havlir, Diane

“…BackgroundHuman immunodeficiency virus (HIV) infection may increase the burden of malaria by increasing susceptibility to infection or by decreasing the…”
Get full text